<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T17:57:49Z</responseDate>
  <request identifier="oai:figshare.com:article/34034911" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34034911</identifier>
        <datestamp>2026-09-30T17:28:55Z</datestamp>
        <setSpec>category_15</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Low-dose/high-stress exposure trends towards reduced hippocampal neurogenesis and increased astrogliosis in the CA1 and CA3 regions.&lt;/p&gt;</dc:title>
          <dc:creator>Rashelle Lashley (7302038)</dc:creator>
          <dc:creator>Joshua Brian Foster (20175776)</dc:creator>
          <dc:creator>Xueqin Wang (350340)</dc:creator>
          <dc:creator>Albert John Muhleman (20175779)</dc:creator>
          <dc:creator>Samuel Weaver (1344039)</dc:creator>
          <dc:creator>Edison Lin (25145140)</dc:creator>
          <dc:creator>Liching Lai (25145143)</dc:creator>
          <dc:creator>Chien-liang Glenn Lin (16856919)</dc:creator>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>related chemical agents</dc:subject>
          <dc:subject>investigational compound designed</dc:subject>
          <dc:subject>including chronic pain</dc:subject>
          <dc:subject>improve translational rigor</dc:subject>
          <dc:subject>robust behavioral phenotypes</dc:subject>
          <dc:subject>like behavioral phenotypes</dc:subject>
          <dc:subject>standardize animal models</dc:subject>
          <dc:subject>harlan involving exposure</dc:subject>
          <dc:subject>experimental conditions evaluated</dc:subject>
          <dc:subject>gulf war illness</dc:subject>
          <dc:subject>male sd rats</dc:subject>
          <dc:subject>experimental conditions</dc:subject>
          <dc:subject>behavioral assessments</dc:subject>
          <dc:subject>gulf war</dc:subject>
          <dc:subject>exposure paradigms</dc:subject>
          <dc:subject>animal sources</dc:subject>
          <dc:subject>rats using</dc:subject>
          <dc:subject>rats may</dc:subject>
          <dc:subject>subsequently modified</dc:subject>
          <dc:subject>stress levels</dc:subject>
          <dc:subject>rat model</dc:subject>
          <dc:subject>psychological stress</dc:subject>
          <dc:subject>original objective</dc:subject>
          <dc:subject>neuropsychiatric symptoms</dc:subject>
          <dc:subject>mood problems</dc:subject>
          <dc:subject>mild stress</dc:subject>
          <dc:subject>initially attempted</dc:subject>
          <dc:subject>continued efforts</dc:subject>
          <dc:subject>cognitive impairment</dc:subject>
          <dc:subject>better interpret</dc:subject>
          <dc:description>&lt;p&gt;Following behavioral assessments (the above low-dose/high-stress exposure study), a subset of rats was euthanized to examine markers for astrocytes (GFAP&lt;sup&gt;+&lt;/sup&gt;), parvalbumin-positive interneurons (PV&lt;sup&gt;+&lt;/sup&gt;), and newborn neurons (DCX&lt;sup&gt;+&lt;/sup&gt;) in hippocampal regions using immunohistochemical staining. For each staining, 3–4 animals and at least 3 sections per animal were analyzed. Data were analyzed by two-way ANOVA. &lt;b&gt;(A-C) the GFAP immunoreactivity quantification&lt;/b&gt;. DG, n = 27–33; CA1, n = 31–34; CA3, n = 31–36. &lt;b&gt;(D) the number of PV&lt;/b&gt;&lt;sup&gt;&lt;b&gt;+&lt;/b&gt;&lt;/sup&gt; &lt;b&gt;neurons&lt;/b&gt;. n = 22–26. &lt;b&gt;(E) the number of DCX&lt;/b&gt;&lt;sup&gt;&lt;b&gt;+&lt;/b&gt;&lt;/sup&gt; &lt;b&gt;newborn neurons&lt;/b&gt;. n = 29–39. Two-way ANOVA revealed a significant main effect of the GW exposure for GFAP - CA1, CA3, and DCX – DG; however, Bonferroni post hoc tests showed no significant differences among the four groups.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-30T17:28:43Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0337157.g004</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Low-dose_high-stress_exposure_trends_towards_reduced_hippocampal_neurogenesis_and_increased_astrogliosis_in_the_CA1_and_CA3_regions_p_/34034911</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
